Homo sapiens Protein: HLA-DQA1 | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||||||
InnateDB Protein | IDBP-81103.6 | ||||||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||||
Gene Symbol | HLA-DQA1 | ||||||||||||||||||||||||||
Protein Name | major histocompatibility complex, class II, DQ alpha 1 | ||||||||||||||||||||||||||
Synonyms | |||||||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||||||
Ensembl Protein | ENSP00000364087 | ||||||||||||||||||||||||||
InnateDB Gene | IDBG-81099 (HLA-DQA1) | ||||||||||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||||||
Function | Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading. | ||||||||||||||||||||||||||
Subcellular Localization | Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-pass type I membrane protein. Golgi apparatus, trans-Golgi network membrane; Single-pass type I membrane protein. Endosome membrane; Single- pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Note=The MHC class II complex transits through a number of intracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation. | ||||||||||||||||||||||||||
Disease Associations | |||||||||||||||||||||||||||
Tissue Specificity | |||||||||||||||||||||||||||
Comments | |||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 11 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
|
||||||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||||||
InterPro |
IPR001003
MHC class II, alpha chain, N-terminal IPR003597 Immunoglobulin C1-set IPR007110 Immunoglobulin-like domain IPR011162 MHC classes I/II-like antigen recognition protein IPR013162 CD80-like, immunoglobulin C2-set |
||||||||||||||||||||||||||
PFAM |
PF00993
PF07654 PF08205 |
||||||||||||||||||||||||||
PRINTS | |||||||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||||||
SMART |
SM00920
SM00407 |
||||||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||||||
Modification | |||||||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||||||
SwissProt | P01909 | ||||||||||||||||||||||||||
PhosphoSite | PhosphoSite- | ||||||||||||||||||||||||||
TrEMBL | Q67AI2 | ||||||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||||||
Entrez Gene | 3117 | ||||||||||||||||||||||||||
UniGene | Hs.706240 | ||||||||||||||||||||||||||
RefSeq | |||||||||||||||||||||||||||
HUGO | HGNC:4942 | ||||||||||||||||||||||||||
OMIM | 146880 | ||||||||||||||||||||||||||
CCDS | CCDS4752 | ||||||||||||||||||||||||||
HPRD | 06765 | ||||||||||||||||||||||||||
IMGT | |||||||||||||||||||||||||||
EMBL | AF109734 AF322867 AF322868 AF322869 AF322870 AF395697 AF395698 AF395699 AF395700 AH013281 AH013282 AH013283 AH013284 AH013285 AH013286 AH013287 AK313975 AL662789 AM042559 AM042560 AY197775 AY206406 AY375955 AY375956 AY375957 AY375958 AY375959 AY375960 AY375961 AY375962 AY375963 AY375964 AY375972 AY375973 AY375974 AY375986 AY375987 AY547314 AY585236 AY663395 AY663398 AY663400 AY663406 AY663411 AY663413 BC008585 BC157865 BX248406 CR450297 DQ178400 DQ178401 DQ178402 DQ178403 DQ178404 DQ178405 DQ178406 DQ178407 DQ178408 DQ178409 DQ178410 DQ178411 DQ178412 DQ178413 DQ178414 DQ178415 J00199 L34082 L34083 L34084 L34085 L34086 L34089 L34090 L34092 L34093 L34094 L42625 L46875 L46876 L46877 L46878 L46880 L46881 M11124 M16995 M17846 M20431 M20506 M29613 M29616 M34997 M34999 M83887 U03675 U85035 U92032 X00033 X00370 X00452 Z84489 | ||||||||||||||||||||||||||
GenPept | AAA35772 AAA59707 AAA59754 AAA59757 AAA59758 AAA59759 AAA59760 AAA59774 AAA74633 AAA85334 AAB41891 AAB60341 AAB91990 AAC41950 AAC41951 AAC41952 AAC41953 AAC41954 AAC41957 AAC41958 AAC41960 AAC41961 AAC41962 AAD56720 AAH08585 AAI57866 AAK11577 AAM69677 AAO45622 AAO47362 AAQ89959 AAQ89960 AAQ89961 AAQ89962 AAQ89963 AAQ89964 AAQ89965 AAQ89966 AAQ89967 AAQ89968 AAQ89976 AAQ89977 AAQ89978 AAQ89990 AAQ89991 AAQ91110 AAQ91111 AAQ91112 AAQ91113 AAQ91114 AAQ91115 AAQ91433 AAS49496 AAT09985 AAU87978 AAU87987 AAU87992 AAU88007 AAU88022 AAU88028 ABA86855 ABA86856 ABA86857 ABA86858 BAG36689 CAA24917 CAA25141 CAB06491 CAG29293 CAI18230 CAJ14960 CAJ14961 CAM26191 | ||||||||||||||||||||||||||